S&P Global Ratings upgrades Synopsys debt. Synopsys stock is valued at EUR 82.1 billion

Published on 10/28/2026 at 13:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

S&P lifts its 2029 EBITDA margin forecast to 49 percent from 45 percent. Synopsys stock costs EUR 425.75 on October 28, 2026 versus EUR 425.00.

Credit profile and growth plan

S&P Global Ratings raised Synopsys to BBB+ from BBB on October 26, 2026.
The 2029 EBITDA margin forecast increased to 49 percent from 45 percent.
Synopsys stock trades at EUR 425.75 at 1:00 p.m. CET at Lang & Schwarz on October 28, 2026, 0.18 percent above the Xetra close of October 27, 2026.
Fiscal year 2027 revenue guidance is USD 11.10 billion to USD 11.20 billion.

Synopsys Inc., US8716071076, Illustration mit AI erstellt.

Synopsys Inc. (ISIN US8716071076) was trading at EUR 425.75 at Lang & Schwarz on October 28, 2026 at 1:00 p.m. CET, 0.18 percent above the Xetra close of October 27, 2026 at EUR 425.00. On October 26, 2026, S&P Global Ratings raised Synopsys and its debt to BBB+ from BBB, with a stable outlook.

Rating upgrade rests on growth

S&P said it lifted its annual revenue growth expectations for 2027 through 2029 to the mid-teens percentage area from 10 percent. Its 2029 EBITDA margin forecast rose to 49 percent from 45 percent, while its forecast for 2026 revenue reached USD 9.718 billion and adjusted EBITDA reached USD 4.341 billion.

The rating agency linked the stronger view to Synopsys' long-term guidance, Ansys integration and cash generation. It also said the company could use up to 50 percent of cash flow for share buybacks, while a several-billion-dollar acquisition or greater AI displacement risk could pressure the rating.

What does the guidance mean?

Synopsys' September 30, 2026 Investor Day set fiscal year 2027 revenue guidance at USD 11.10 billion to USD 11.20 billion and a non-GAAP operating margin midpoint of 44.0 percent, according to the company's Investor Day release. That guidance gives the credit upgrade a measurable operating framework, but it also leaves execution and acquisition integration as key variables.

Three dated milestones

On September 30, 2026, Synopsys published fiscal year 2027 targets of USD 11.10 billion to USD 11.20 billion in revenue through its Investor Day release. On October 5, 2026, the company entered a USD 1.00 billion accelerated share repurchase agreement with JPMorgan Chase, including an initial delivery of 1,735,000 shares, according to its release. On October 26, 2026, S&P Global Ratings completed the sequence with the BBB+ upgrade.

Next date is January 5

The repurchase agreement sets January 5, 2027, as the deadline for final settlement of any remaining shares. The arrangement therefore links the credit story to a defined capital-return timetable.

Stock stays below its yearly high

Synopsys has a market capitalization of EUR 82.1 billion and a 52-week range of EUR 318.00 to EUR 464.50 as of October 28, 2026. The current quote sits inside that range while the new credit assessment adds a separate measure of balance-sheet confidence.

The further course of trading is shown by the continuously updated real-time quote of Synopsys stock.